Table 3 The frequency of abnormal components in MetS subjects between 2005 and 2014
| Â | Female MetS | P value | Male MetS | P value | ||
|---|---|---|---|---|---|---|
2005 (n = 208) | 2014 (n = 310) | 2005 (n = 101) | 2014 (n = 169) | |||
Abnormal component | ||||||
 WC | 191 (91.83) | 288 (92.90) | 0.649 | 88 (87.13) | 143 (84.62) | 0.57 |
 FBG | 73 (35.10) | 234 (75.48) | <0.001 | 66 (65.35) | 129 (76.33) | 0.051 |
 BP | 202 (97.12) | 269 (86.77) | <0.001 | 98 (97.03) | 158 (93.49) | 0.204 |
 TG | 75 (36.06) | 170 (54.84) | <0.001 | 54 (53.47) | 107 (63.31) | 0.11 |
 HDL | 157 (75.48) | 150 (48.39) | <0.001 | 32 (31.68) | 30 (17.75) | 0.008 |
 MetS z score | 1.74 ± 2.29 | 1.97 ± 2.53 | <0.001 | 1.01 ± 2.38 | 2.51 ± 2.79 | <0.001 |